These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10556738)
1. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Fang J; Fang C; Sung KC; Chen H Int J Pharm; 1999 Nov; 191(1):33-42. PubMed ID: 10556738 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of topical application of clobetasol 17-propionate from various cream bases. Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH Drug Dev Ind Pharm; 1999 Jan; 25(1):7-14. PubMed ID: 10028413 [TBL] [Abstract][Full Text] [Related]
3. Topical application of clobetasol 17-propionate from various cream bases by using Wistar rat as an animal model. Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH Kaohsiung J Med Sci; 1998 May; 14(5):286-93. PubMed ID: 9619014 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of clobetasol propionate in different vehicles. Franz TJ; Lehman PA; Feldman SR; Spellman MC Skin Pharmacol Appl Skin Physiol; 2003; 16(4):212-6. PubMed ID: 12784060 [TBL] [Abstract][Full Text] [Related]
5. Different approaches for improving skin accumulation of topical corticosteroids. Senyiğit T; Padula C; Ozer O; Santi P Int J Pharm; 2009 Oct; 380(1-2):155-60. PubMed ID: 19635541 [TBL] [Abstract][Full Text] [Related]
6. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment. Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273 [TBL] [Abstract][Full Text] [Related]
7. In vitro penetration through the skin layers of topically applied glucocorticoids. Carrer V; Alonso C; Oliver MA; Coderch L Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery. Şenyiğit T; Sonvico F; Rossi A; Tekmen I; Santi P; Colombo P; Nicoli S; Özer Ö Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035957 [TBL] [Abstract][Full Text] [Related]
9. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro. Mueller B; Anissimov YG; Roberts MS Pharm Res; 2003 Nov; 20(11):1835-7. PubMed ID: 14661929 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of clobetasol spray: factors beyond patient compliance. Bhutani T; Koo J; Maibach HI J Dermatolog Treat; 2012 Feb; 23(1):11-5. PubMed ID: 21254848 [TBL] [Abstract][Full Text] [Related]
11. Effect of Different Skin Penetration Promoters in Halobetasol Propionate Permeation and Retention in Human Skin. Carvajal-Vidal P; Mallandrich M; García ML; Calpena AC Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160818 [TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants. Cherian MP; AbdulJabbar M Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195 [No Abstract] [Full Text] [Related]
13. Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Weigmann H; Lademann J; v Pelchrzim R; Sterry W; Hagemeister T; Molzahn R; Schaefer M; Lindscheid M; Schaefer H; Shah VP Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):46-53. PubMed ID: 10325583 [TBL] [Abstract][Full Text] [Related]
14. Chromatographic method for clobetasol propionate determination in hair follicles and in different skin layers. Ângelo T; Cunha-Filho MS; Gelfuso GM; Gratieri T Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27502902 [TBL] [Abstract][Full Text] [Related]
15. Characterization of transdermal solute transport induced by low-frequency ultrasound in the hairless rat skin. Mutoh M; Ueda H; Nakamura Y; Hirayama K; Atobe M; Kobayashi D; Morimoto Y J Control Release; 2003 Sep; 92(1-2):137-46. PubMed ID: 14499192 [TBL] [Abstract][Full Text] [Related]
16. Acoustic cavitation as an enhancing mechanism of low-frequency sonophoresis for transdermal drug delivery. Ueda H; Mutoh M; Seki T; Kobayashi D; Morimoto Y Biol Pharm Bull; 2009 May; 32(5):916-20. PubMed ID: 19420764 [TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081 [TBL] [Abstract][Full Text] [Related]
18. Clobetasol-loaded nanostructured lipid carriers for epidermal targeting. Silva LA; Andrade LM; de Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF J Pharm Pharmacol; 2016 Jun; 68(6):742-50. PubMed ID: 27061573 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution. Bodenlenz M; Dragatin C; Liebenberger L; Tschapeller B; Boulgaropoulos B; Augustin T; Raml R; Gatschelhofer C; Wagner N; Benkali K; Rony F; Pieber T; Sinner F Pharm Res; 2016 Sep; 33(9):2229-38. PubMed ID: 27271272 [TBL] [Abstract][Full Text] [Related]
20. A novel foam vehicle for delivery of topical corticosteroids. Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]